News > Bharat Biotech's partner Ocugen seeks nod for Covaxin in Canada
Bharat Biotech's partner Ocugen seeks nod for Covaxin in Canada
Business Today | 16/07/2021 04:30 PM | Click to read full article
Ocugen Inc., Bharat Biotech's partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing.
The move follows the release by Bharat Biotech of Phase3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday.
